SOUTH SAN FRANCISCO, Calif., March 4, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report year-end 2013 results on Tuesday March 18th, 2014. A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm ET (1:30 p.m. PT).
Help employers find you! Check out all the jobs and post your resume.
